Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 334.50
Bid: 331.50
Ask: 333.00
Change: 6.00 (1.83%)
Spread: 1.50 (0.452%)
Open: 323.00
High: 344.50
Low: 323.00
Prev. Close: 328.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Numis cuts Kingfisher but raises Next

Tue, 11th Oct 2022 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

----------

FTSE 100

----------

Citigroup raises Centrica to 'buy' (neutral) - price target 81 (97) pence

----------

Citigroup raises Compass price target to 2,260 (2,170) pence - 'buy'

----------

Deutsche Bank raises Coca-Cola HBC target to 2,750 (2,700) pence - 'buy'

----------

Bernstein cuts Tesco price target to 250 (330) pence - 'outperform'

----------

Credit Suisse raises Anglo American target to 3,440 (3,290) pence - 'outperform'

----------

Credit Suisse cuts Antofagasta price target to 1,020 (1,040) pence - 'neutral'

----------

Credit Suisse raises Fresnillo price target to 650 (630) pence - 'underperform'

----------

Credit Suisse raises Rio Tinto price target to 5,800 (5,600) pence - 'outperform'

----------

Credit Suisse raises Glencore price target to 760 (720) pence - 'outperform'

----------

Credit Suisse cuts Severn Trent price target to 2,680 (2,800) pence - 'neutral'

----------

JPMorgan raises DS Smith price target to 388 (378) pence - 'overweight'

----------

Credit Suisse cuts Rightmove price target to 490 (608) pence - 'neutral'

----------

JPMorgan cuts Barclays price target to 180 (200) pence - 'neutral'

----------

JPMorgan cuts NatWest price target to 300 (350) pence - 'neutral'

----------

JPMorgan cuts Lloyds Banking price target to 56 (64) pence - 'overweight'

----------

Numis cuts Kingfisher to 'sell' (reduce) - price target 150 (215) pence

----------

Numis raises Next to 'buy' (add) - price target 6,800 (7,000) pence

----------

FTSE 250

----------

HSBC cuts Sirius Real Estate price target to 124 (138) pence - 'buy'

----------

JPMorgan cuts Virgin Money UK price target to 165 (200) pence - 'neutral'

----------

Barclays cuts Moneysupermarket.com target to 220 (230) pence - 'equal weight'

----------

Barclays cuts Future price target to 1,975 (2,500) pence - 'overweight'

----------

Berenberg cuts Marshalls price target to 280 (380) pence - 'hold'

----------

JPMorgan cuts Johnson Matthey price target to 2,150 (2,600) pence - 'neutral'

----------

Goldman Sachs cuts TI Fluid price target to 132 (179) pence - 'neutral'

----------

SMALL CAP

----------

Jefferies reinitiates ITM Power with 'buy' - price target 185 pence

----------

Jefferies reinitiates Ceres Power with 'hold' - price target 365 pence

----------

Citigroup cuts Ceres Power price target to 800 (1500) pence - 'buy'

----------

Barclays cuts Just Eat Takeaway target to 1,490 (1,940) pence - 'equal weight'

----------

RBC raises Oxford BioMedica price target to 1,110 (1,020) pence - 'outperform'

----------

Barclays starts Glenveagh Properties with 'overweight' - price target 1.20 EUR

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
22 Sep 2021 16:54

LONDON MARKET CLOSE: Stocks up as Evergrande fears soothed before Fed

LONDON MARKET CLOSE: Stocks up as Evergrande fears soothed before Fed

Read more
22 Sep 2021 09:16

TOP NEWS: Oxford BioMedica sales double; Serum Institute buys stake

TOP NEWS: Oxford BioMedica sales double; Serum Institute buys stake

Read more
22 Sep 2021 07:03

Oxford Biomedica swings to profit on Covid-19 vaccine sales

(Sharecast News) - Covid-19 vaccine producer Oxford Biomedica swung to a profit in the half year on the back of a surge in revenues through its partnership deal with AstraZeneca and announced that Serum Institute of India has agreed to invest £50m in the group in return for a 3.9% stake in the company.

Read more
22 Sep 2021 07:03

Oxford Biomedica swings to profit on Covid-19 vaccine sales

(Sharecast News) - Covid-19 vaccine producer Oxford Biomedica swung to a profit in the half year on the back of a surge in revenues through its partnership deal with AstraZeneca and announced that Serum Institute of India has agreed to invest £50m in the group in return for a 3.9% stake in the company.

Read more
21 Sep 2021 09:14

UPDATE 2-FTSE 100 recovers 1% on energy, healthcare stock boost; Entain jumps

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Kingfisher top FTSE 100 loser despite positive results* Royal Dutch Shell sells U.S. oilfield assets* Stagecoast surges on merger talks wit...

Read more
15 Sep 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
6 Aug 2021 10:55

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

Read more
28 Jul 2021 12:49

UK wants world vaccinated by middle of 2022, Raab says

OXFORD, England, July 28 (Reuters) - British Foreign Secretary Dominic Raab warned that the world would not be vaccinated until 2024 under current rates and urged other countries to join Britain in donating shots to poorer nations to bring that d...

Read more
15 Jul 2021 14:54

EXECUTIVE CHANGES: Oxford BioMedica adds former Teva exec to board

EXECUTIVE CHANGES: Oxford BioMedica adds former Teva exec to board

Read more
15 Jul 2021 09:45

BROKER RATINGS: Citigroup prefers Beazley over Hiscox and Lancashire

BROKER RATINGS: Citigroup prefers Beazley over Hiscox and Lancashire

Read more
6 Jul 2021 15:52

IN BRIEF: Oxford BioMedica exec sells shares after options exercise

IN BRIEF: Oxford BioMedica exec sells shares after options exercise

Read more
24 Jun 2021 09:49

BROKER RATINGS: Deutsche raises GSK; HSBC cuts BP to Hold

BROKER RATINGS: Deutsche raises GSK; HSBC cuts BP to Hold

Read more
21 Jun 2021 09:34

BROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado

BROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado

Read more
18 Jun 2021 14:26

AstraZeneca must use Britain's plant if needed to meet EU's vaccine commitments - EU lawyer

June 18 (Reuters) - AstraZeneca must deliver COVID-19 vaccines to the European Union also from a factory in Britain if it is needed to meet its commitments with the EU, a judge ruled on Friday, according to a lawyer representing the EU.The company...

Read more
18 Jun 2021 14:06

UPDATE 5-EU loses bid for speedier AstraZeneca vaccine deliveries

* Judge orders AstraZeneca to deliver doses by strict deadlines* EU had asked for more doses to be shipped earlier* AstraZeneca may have breached contract in reserving doses for UK* Second legal case will establish whether contract was breached (...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.